Qube Research & Technologies LTD Gilead Sciences, Inc. Call Options Transaction History

Qube Research & Technologies LTD

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $3.46 Million - $3.99 Million	54,800 New	54,800 $3.76 Million
Q4 2023 Feb 13, 2024	SELL	$73.27 - $83.09 $2.18 Million - $2.47 Million	-29,700 Reduced 70.55%	12,400 $1 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $3.09 Million - $3.37 Million	41,800 Added 13933.33%	42,100 $3.15 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $22,803 - $26,010	300 New	300 $23,000

1,893

1.02B

12M

8.96M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.